Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aussie Government Panel Accuses TGA Of Laxity In Approvals

This article was originally published in PharmAsia News

Executive Summary

One arm of the Australian government is accusing the Therapeutics Goods Administration of slipshod review work that allows questionable drugs and medical devices on the market. The Prostheses and Devices Committee, a government-appointed panel, reported the TGA has cleared some products despite a lack of support by the clinical studies submitted for the approval process. The committee said some of its members, who include medical professionals, believe TGA's review procedures are inadequate. The committee is considering how to coordinate the federal process of approving products with the programs for funding them. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts